News Release

January 11, 2005

Contact: Maureen McGuire, 860-679-4523

New Treatments for Peripheral Vascular Disease

Topic of February 1st Discovery Series

FARMINGTON, CONN. – New treatments for peripheral vascular disease, including a new approach to prevent strokes through carotid angioplasty and new treatments to reduce leg pain and remove unsightly varicose veins, will be explored during the next Discovery Series program on Tuesday, February 1, at the University of Connecticut Health Center.

As always, the Discovery Series is free and will be held at 7 p.m., in the Health Center’s Keller Auditorium. Earlier that evening, from 5:30 p.m. to 7 p.m., free screenings for peripheral vascular disease will be offered in the Keller Lobby. Registration is required for both the lecture and the screening. Please call 800-535-6232 or 860-679-7692.

Peripheral vascular disease causes serious blockages to veins and arteries outside the heart, including blockages in the legs and the carotid arteries – the main blood supply to the brain. People with peripheral vascular disease are at increased risk for heart attack and stroke.

During the Discovery Series, speakers will include Michael S. Dahn, M.D., an endovascular surgeon with the Pat and Jim Calhoun Cardiology Center and Melih Arici, M.D., a specialist in vascular interventional treatments with the Health Center’s Department of Radiology.

UConn Health includes the schools of medicine and dental medicine, the UConn Medical Group, University Dentists, and John Dempsey Hospital. Home to Bioscience Connecticut, UConn Health pursues a mission of providing outstanding health care education in an environment of exemplary patient care, research and public service. More information about UConn Health is available at

Note: News professionals are invited to visit the UConn Health Today news page ( for regularly updated news and feature stories, photos and media stories. News releases are archived at UConn Health news and information is also available on Facebook, Twitter and YouTube.